Importantly, we observed significantly enriched CD8+ T cells in BRCA1 carriers (χ2 test p = 4.07 × 10−8), suggesting an early role for the adaptive immune system prior to tumor initiation (Fig. 5A). Here, BRCA1 is linked to neoplasm.